Drug intelligence / Profile preview

GQ-501

Development stage
Preclinical
Lead developer
Pacira BioSciences
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies
Administration
Intraarticular
01

Overview

GQ-501 is a gene therapy drug candidate developed for the treatment of osteoarthritis. It is a helper-dependent adenoviral vector that expresses two therapeutic proteins: proteoglycan 4 (also known as lubricin) and interleukin-1 receptor antagonist (IL-1Ra). The mechanism of action involves stimulating IL-1Ra, which inhibits inflammatory signaling mediated by interleukin 1, and modulating PRG4/lubricin, which plays a role in joint lubrication and cartilage protection. The drug is being developed by GQ Bio Therapeutics GmbH (formerly GeneQuine Biotherapeutics GmbH), with its highest development phase reported as preclinical[1][2].

Other names
HCAd-NFkB-IL-1RA-PRG4HCAd-NFkB-IL1RA-PRG4HCAd-NFkB-IL 1RA-PRG4HCAd-NFkB::IL-1RA/PRG4HCAd-NFkb::IL-1Ra; EF1::Prg4HCAd-NFκB::IL-1Ra-EF1::Prg4
02

Targets

IL1R1 (Interleukin-1 Receptor Type 1)IL1RN (Interleukin-1 receptor antagonist)PRG4 (Proteoglycan 4)

Beyond the preview

Go deeper on GQ-501.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GQ-501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call